HCA Healthcare (NYSE:HCA) Given New $521.00 Price Target at Royal Bank Of Canada

HCA Healthcare (NYSE:HCA) had its price target lifted by analysts at Royal Bank Of Canada from $496.00 to $521.00 in a research note issued to investors on Friday, Benzinga reports. The firm presently has an “outperform” rating on the stock. Royal Bank Of Canada‘s price objective points to a potential upside of 8.45% from the company’s previous close.

Other equities research analysts have also recently issued reports about the stock. Mizuho set a $495.00 price objective on shares of HCA Healthcare in a research report on Wednesday. Sanford C. Bernstein reissued a “market perform” rating on shares of HCA Healthcare in a report on Wednesday, July 15th. Leerink Partners reaffirmed an “outperform” rating and set a $492.00 price target on shares of HCA Healthcare in a report on Friday, September 18th. BMO Capital Markets began coverage on HCA Healthcare in a research note on Tuesday, September 22nd. They set an “outperform” rating and a $495.00 price objective on the stock. Finally, Oppenheimer lowered their price objective on HCA Healthcare from $520.00 to $485.00 and set an “outperform” rating for the company in a research note on Monday, July 27th. Sixteen investment analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat, the company has an average rating of “Moderate Buy” and an average price target of $475.70.

HCA Healthcare Price Performance

HCA traded up $2.31 on Friday, reaching $480.38. 398,531 shares of the company’s stock were exchanged, compared to its average volume of 1,341,891. HCA Healthcare has a twelve month low of $353.99 and a twelve month high of $556.52. The stock has a market cap of $104.00 billion, a PE ratio of 15.91, a P/E/G ratio of 1.53 and a beta of 1.10. The stock’s fifty day moving average price is $436.10 and its 200-day moving average price is $444.90.

HCA Healthcare (NYSE:HCA) last released its quarterly earnings data on Tuesday, October 27th. The company reported $7.22 earnings per share (EPS) for the quarter, topping the consensus estimate of $6.65 by $0.57. HCA Healthcare had a net margin of 8.61% and a negative return on equity of 198.52%. The firm had revenue of $19.85 billion during the quarter, compared to analysts’ expectations of $19.33 billion. During the same period last year, the business earned $6.96 earnings per share. HCA Healthcare’s revenue was up 3.6% compared to the same quarter last year. As a group, research analysts predict that HCA Healthcare will post 30.20 earnings per share for the current fiscal year.

Institutional Trading of HCA Healthcare

Hedge funds and other institutional investors have recently made changes to their positions in the business. MidFirst Bank acquired a new stake in shares of HCA Healthcare during the second quarter worth $28,000. Clearstead Trust LLC bought a new position in HCA Healthcare in the 2nd quarter valued at about $29,000. Latitude Advisors LLC acquired a new position in shares of HCA Healthcare during the 3rd quarter worth approximately $32,000. Cedar Mountain Advisors LLC acquired a new position in shares of HCA Healthcare in the 1st quarter valued at approximately $33,000. Finally, Delos Wealth Advisors LLC acquired a new stake in shares of HCA Healthcare during the 2nd quarter worth approximately $35,000. 62.73% of the stock is currently owned by institutional investors and hedge funds.

About HCA Healthcare

HCA Healthcare, Inc is a healthcare services company that operates hospitals, ambulatory surgery centers, emergency care facilities, physician practices and other healthcare sites. Its facilities provide a broad range of services, including acute and emergency care, surgery, cardiology, oncology, women’s and children’s services, behavioral health and outpatient care.

The company serves patients primarily across the United States through a network of healthcare facilities in numerous states.